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ABSTRACT 
Manganese is an essential micronutrient for mammals, however high manganese 
concentrations cause adverse health effects. Swine renal betaine aldehyde dehydrogenase 
catalyzes the synthesis of glycine betaine, which plays an important role in renal cells 
osmoregulation. In vitro inactivation of BADH was observed by incubating the purified 
enzyme in the presence of 1 mM MnCl2 under physiological and low ionic strength 
conditions. Enzyme inactivation followed first order kinetics in a monophasic process with 
an inactivation constant of 0.126 ± 0.011 min-1 and 0.137 ± 0.017 at physiological and low 
ionic strength, respectively. Enzyme inactivation was not prevented by physiological ionic 
strength, nor by the substrates NAD+ and betaine aldehyde at saturated concentrations. The 
enzyme was reactivated with DTT and GSH. Native-PAGE of the inactivated enzyme 
showed no change in the tetrameric conformation. Intrinsic protein fluorescence studies 
demonstrated an increased exposure of the tryptophan residues to the aqueous solvent when 
the enzyme was incubated with Mn2+. These results suggest that BADH inactivation by 
Mn2+ may result from the oxidation of cysteines, which induces changes in the tertiary 
structure of the enzyme. 
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INTRODUCTION 
Manganese is an essential micronutrient for 
mammals and is involved in metabolic 
pathways as a cofactor for several enzymes 
(Barceloux, 1999). High manganese 
concentrations cause adverse health effects. 
Exposure to manganese through inhalation 
has been observed in industrial workers and 
in urban areas with high traffic density 
(Iregren, 1999; Joselow et al., 1978; Salehi 
et al., 2006). Iregren et al. found that 
exposure to air concentrations of 1 mg of 
Mn/m3 can lead to adverse respiratory, 
neurological, and reproductive effects. 
Under normal conditions higher manganese 
concentrations are localized in the lungs, 
brain, kidneys, liver, pancreas, bone, and 
blood (Bush et al., 1995; Rahil-Khazen et 
al., 2002; Erdogan et al., 2004). The 
majority of the studies on the toxic effects 
of manganese, known as manganism, have 
focused on the central nervous system 
because manganese may cause neurological 
symptoms similar to those of Parkinson’s 
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disease (Salehi et al., 2006). Other sources 
of manganese intoxication are from 
organometallic fungicides and fertilizers 
(Guven et al., 1998; Huang and Lin, 2004). 
Guven et al. found manganese 
accumulation in the kidneys in both fetal 
and female rats during pregnancy and a 
variety of histological effects in renal tissue 
when female Wistar rats were exposed 
orally to the fertilizers Propineb and Maneb 
(Guven et al., 1998). The toxicological 
effects of fertilizers have also been 
observed in humans as reported by Huang 
and Lin where acute renal failure was 
associated with the ingestion of manganese-
containing fertilizer (Huang and Lin, 2004).  
 
During the physiological mechanism that 
concentrates urine, the renal medulla cell 
must synthesize and accumulate osmolytes 
to achieve osmoregulation (Burg, 1995). 
The main renal osmolytes are 
glycerophosphorylcholine, glycine betaine, 
sorbitol, and mannitol (Bagnasco et al., 
1986). Glycine betaine is synthesized in two 
choline oxidation steps. The first is 
catalyzed by choline dehydrogenase 
(Grossman et al., 1989) and the second by 
betaine aldehyde dehydrogenase (BADH; 
EC 1.2.1.8) (Figueroa-Soto et. al., 1999). 
Swine renal BADH has been purified 
(Guzman-Partida and Valenzuela-Soto, 
1998), kinetically characterized (Figueroa-
Soto and Valenzuela-Soto, 2000), and the 
required cations studied (Valenzuela-Soto et 
al., 2003; Valenzuela-Soto et al., 2005). 
Renal BADH needs physiological ionic 
strength induced by monovalent cations to 
maintain its stability (Valenzuela-Soto et 
al., 2003). The functional conformation of 
BADH is a 52-kilodalton subunit homo-
tetramer; the tetramer is dissociated to 
inactive dimers and monomers in the 
absence of physiological ionic strength 
(Valenzuela-Soto et al., 2003). These 
correspond to the environment surrounding 
the enzyme during the concentrating 
mechanism of urine (García-Perez and 
Burg, 1991). In contrast, K+ enhances the 
stability of BADH against thermal 
denaturation, which cannot be achieved by 
Mg2+ at the same ionic strength and 
suggests that the monovalent cation has a 
specific effect (Valenzuela-Soto et al, 
2005).  
 
BADH has been classified as aldehyde 
dehydrogenase (ALDH) class 9; thus, 
kidney BADH is an ALDH9 (Yoshida et al., 
1998). Mono and divalent cations regulate 
yeast, and human liver cytosolic (ALDH1) 
and mitochondrial (ALDH2) aldehyde 
dehydrogenase (Vallari. and Pietruszko, 
1984b; Dickinson and Hywood, 1987; 
Dickinson, 2003). It is known that ALDH2 
is activated by Mg2+, whereas ALDH1 is 
inhibited by Mg2+ (Vallari and Pietruszko, 
1984a; Vallari and Pietruszko, 1984b; Ni et 
al., 1997). The addition of Mg2+ appears to 
decrease the rate of NADH release for 
ALDH1 (Perez-Miller and Hurley, 2003).  
 
Although high Mn2+ concentrations can be 
found in the kidneys, little is known about 
the potentially adverse renal effect of this 
metal. Ponnapakkam et al. found that 
Sprague-Dawley male rats treated with high 
manganese dose developed severe renal 
disease (Ponnapakkam et al., 2003). Wistar 
Albino rats treated with gentamicin and 
manganese chloride (20 mg kg-1 per day) 
showed severe tubular necrosis (Atessahin 
et al., 2003).  For rats Arregui et al. found 
that intrarenal administration of Mn2(CO)10 
increased water and sodium excretion 
(Arregui et al., 2004). This finding suggests 
defective rat kidney osmoregulation. 
Impaired renal osmoregulation has a 
significant impact on kidney physiology and 
therefore health. Recently, mammals have 
been exposed to increased Mn2+ 
concentrations from fuel emissions and 
chemical products, such as fertilizers and 
fungicides. In this study, we evaluated the 
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effect of Mn2+ on the activity and stability 
of BADH since this enzyme is directly 
related to renal osmoregulation.  
 
MATERIALS AND METHODS 
 
BADH Purification and Activity Assay  
BADH was purified from porcine kidney 
and its activity was assayed at 30 ºC as 
previously reported (Guzman-Partida and 
Valenzuela-Soto, 1999). The pure enzyme 
was stored at 20 oC in a 10 mM potassium 
phosphate buffer, pH 7.0, 1 mM EDTA, 10 
mM β-mercaptoethanol, 0.2 M KCl and 
10% glycerol. The enzyme (0.15 mg/mL) 
was dialyzed overnight at 4 °C against 10 
mM HEPES-KOH buffer, pH 7.0, 1mM 
EDTA, 10 mM β-mercaptoethanol (buffer 
A), or against buffer A plus 150 mM KCl 
(buffer B). 
 
Effect of Mn2+ Concentration on BADH 
Activity  
MnCl2 concentrations of 0 to 20 mM were 
added to the BADH activity buffer, the 
dialyzed enzyme was added and the activity 
measured immediately afterwards. 
Kinetics of Inactivation by Mn2+. Dialyzed 
BADH (0.15 mg/mL) was incubated at 1 
mM MnCl2 and its remaining activity 
determined by standard assay at the times 
indicated. The kinetics of reactivation was 
studied in enzyme samples partially 
inactivated during 60 min of incubation at 1 
mM MnCl2 plus 5 mM DTT, 
(Dithiothreitol) or 10 mM glutathione 
(GSH). The recovery of activity was 
followed for an additional 120 min. Enzyme 
inactivation and reactivation time courses 
were analyzed by nonlinear fit of the 
experimental data to single exponential 
decay and growth equations, respectively. 
 
Determination of Protein Concentration  
Protein concentration was determined with 
Bradford’s method (Bradford, 1976) using 
the Bio-Rad protein assay reagent with 
bovine serum albumin as the standard.  
Electrophoresis. Samples of dialyzed 
BADH incubated at room temperature with 
0 and 1 mM MnCl2 for 60 min were 
analyzed in 4-15% nondenaturing PAGE 
(Laemmli, 1976) and stained with the silver 
technique (Wray et al., 1981). 
 
Fluorescence Spectroscopy  
Fluorescence spectra were recorded with a 
PTI fluorescence spectrophotometer (PTI-
840) in a quartz cell with a 5nm path length, 
using an excitation wavelength of 296 nm 
and emission wavelength of 300-450 nm. 
BADH in 10 mM HEPES pH 7.0 was 
incubated in the presence of 1 mM MnCl2 
for 30 min before the spectra were recorded. 
Protein concentration was 0.1 mg/mL for all 
experiments, and the measurements were 
carried out at 25 oC. Fluorescence spectral 
centers of mass (intensity-weighted average 
emission wavelengths, λav) were calculated 
according to the following equation: 
 
λav = Σ λI (λ)/ ΣI (λ) 
 
where λ is the emission wavelength and I(λ) 
represents the fluorescence intensity at 
wavelength λ. 
 
Kinetic Analysis  
Activity data were analyzed by nonlinear 
regression using the program Microcal 
Origin (OriginLab Corporation). 
 
RESULTS AND DISCUSSION 
Porcine kidney BADH activity was 
measured at increasing concentrations of 
MnCl2 at low (10 mM HEPES) and 
physiological (0.15 M KCl) ionic strength 
conditions; in both cases, the enzyme was 
inhibited. BADH activity decreased 50 % 
and 70 % at 10 mM Mn2+ at low and 
physiological ionic strength, respectively 
(Fig. 1). Physiological ionic strength seems 
to protect against Mn2+ inactivation. 
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Previously, it was found that the renal 
BADH is slightly protected from 
temperature denaturation by K+ 
(Valenzuela-Soto et al., 2005), and this is in 
accordance with this new result. 
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Figure 1: Effect of MnCl2 concentration on porcine kidney BADH activity. The 
enzyme (0.1 mg/mL) was assayed at 0-20 mM MnCl2 in the  presence (●) and 
absence of KCl (○). Each point is the mean ± SEM of 3 independent experiments. 
 
 
Atessahin et al., did not find changes in 
glutathione peroxidase and catalase 
activities in rat kidney treated with low (2 
mg kg-1 per day) or high (20 mg kg-1 per 
day) MnCl2 dose (Atessahin et al., 2003).  
 
The effect of Mn2+ on kidney BADH 
stability was studied in the presence and 
absence of 0.15 M KCl. Inactivation of the 
enzyme at physiological ionic strength 
incubated with 1 mM Mn2+ followed first 
order kinetics in a monophasic process with 
an inactivation constant (Ki) of 0.126 ± 
0.015 min-1 (Fig. 2). The kinetics of the 
inactivation of BADH at low ionic strength 
was similar; Ki = 0.137 ± 0.015 min-1 (Fig. 
2).  
 
To our knowledge, this is the first report 
regarding the effect of manganese on 
mammal BADH activity and stability. 
Several studies have demonstrated the 
outcome of Mg2+ and/or Ca2+ on the activity 
of ALDHs (Vallari and Pietruszko, 1984a; 
Ni et al., 1997; Dickinson, 2003; Ho and 
Weiner, 2005).  
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Figure 2: (A) Effect of 1 mM MnCl2 on the time-course of porcine kidney BADH 
inactivation in the (A) presence (●) and absence (○) of 0.15 M KCl. BADH (0.1 
mg/mL) was incubated at 25 °C in buffer A plus 1 mM MnCl2. (B) Reactivation by 5 
mM DTT (■), 10 mM GSH (▲) and thionein (▼). Remaining activity was 
determined at the time intervals indicated. Each point is the mean ± SEM of 3 
independent experiments. The line is the result of the best fit of the experimental 
data to a single exponential decay equation. 
 
 
It is known that Mg2+ activates ALDH2, but 
inhibits ALDH1 (Vallari and Pietruszko, 
1984a and b; Ni et al., 1997). Perez-Miller 
et al. found that nicotinamide isomerization 
during turnover plays an important role in 
ALDH2 catalysis (Perez-Miller and Hurley, 
2003). Their data also suggest that the 
addition of Mg2+ ions accelerates the 
nicotinamide isomerization step during 
turnover, thus explaining the activation of 
ALDH2 and the inhibition of ALDH1 by 
Mg2+ (Perez-Miller and Hurley, 2003). 
Muñoz-Clares and Mújica-Jiménez found a 
burst of NADH production in the pre-
steady-state kinetics of amaranth BADH 
indicating that the rate-limiting step occurs 
after the hydride transfer (Muñoz-Clares 
and Mujica-Jimenez, 2001). It is worth 
noting that amaranth and renal BADH share 
similar characteristics including their 
kinetic mechanisms (Figueroa-Soto and 
Valenzuela-Soto, 2000). Therefore, the 
inhibition of kidney BADH by Mn2+ could 
be related to the slow speed in the 
isomerization step similar to that reported 
for Mg2+ in ALDH1 (Perez-Miller and 
Hurley, 2003). 
 
Treatment of the inactive enzyme with DTT 
completely restored enzymatic activity (Fig. 
2B). Reactivation was fast, with 100% of 
activity recovered in 1 h. Similar results 
were obtained with GSH; however, with 
this compound reactivation was slower, 
with 94% of activity recovered at 2 h (Fig. 
2B). Metallothioneins are proteins which 
can bind several metal atoms and they are 
abundant in mammal kidneys (Vasak, 
2005). Therefore, Mn-thionein is an ideal 
candidate for transporting and supplying 
Mn2+ for renal BADH inactivation. With the 
goal of testing this hypothesis, fully 
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inactivated BADH was incubated with 14 
µM thionein for 2 h. The enzyme recovered 
32% of its activity (Fig. 2B).  
The reactivation of BADH by DTT and 
GSH suggests that BADH inactivation in 
vivo could be prevented by the 
physiological reductant GSH. In addition, 
the reactivation data correlates with a 
possible oxidation of cysteines, specifically 
with the site active cysteine, which binds 
the substrate betaine aldehyde. Thioneins 
are the biological chelating agents (Vasak, 
2005). Their effect on BADH inactivation 
indicates that Mn2+ binding is reversible. 
However, we do not know if thionein can 
remove manganese from the catalytic 
cysteine. 
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Figure 3: Substrate effect on renal BADH inactivation by MnCl2. The 
enzyme (0.1 mg/mL) was incubated at 25 °C in buffer A at 1 mM MnCl2  (●), 
or 1 mM NAD+ (▼), or 0.5 mM BA (▲). Remaining activity was determined 
at the time intervals indicated. Each point is the mean ± SEM of 3 
independent experiments, and the line is the best fit of the experimental 
data to a single exponential decay equation. 
 
 
The coenzyme and substrate role played by 
Mn2+ in the inactivation of BADH was 
analyzed by adding 1 mM NAD+ or 0.5 mM 
BA to the incubation medium. Enzyme 
inactivation was not prevented by NAD+ 
nor by the substrate BA under low (data not 
shown) or physiological ionic strength (Fig. 
3). Therefore, in vivo the continued activity 
of BADH depends on GSH when Mn2+ 
concentrations are high.  
 
To determine if the loss of enzyme activity 
during incubation time was related to 
changes in the aggregation state, a native-
PAGE was run. Incubating the enzyme for 
30 min with MnCl2 in the absence of K+ 
does not change its migration profile 
(tetrameric conformation; Fig. 4). Renal 
BADH requires ionic strength to maintain 
its tetrameric conformation indicated by the 
gel as an abundant protein band at 232 kDa 
(tetramer) and another one (less abundant) 
at 125 kDa (dimer) with or without Mn2+ as 
previously reported (Valenzuela-Soto et al., 
2003). This result suggests that Mn2+ is 
inactivating the enzyme because it is acting 
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at the level of a catalytic residue and or 
tertiary structure. 
Since the tetrameric conformation of the 
enzyme did not change, intrinsic tryptophan 
fluorescence studies were carried out to 
determine whether the enzyme’s tertiary 
structure was affected by Mn2+. The 
fluorescence spectra of the enzyme in the 
presence and absence of K+ showed a 
decrease in the maximum and also a red 
shift in fluorescence emission (Fig. 5A). 
The addition of 1 mM Mn2+ to the enzyme 
in the presence and absence of K+ did not 
modify the fluorescence spectra (Fig. 5A).  
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Figure 4: Native-PAGE of kidney BADH. The enzyme without KCl was 
incubated for 30 min lane 1, with 1 mM MnCl2, and lane 2, without divalent 
cation.  
 
 
However, the fluorescence spectral centers 
of mass calculated for the enzyme plus 1 
mM Mn2+ in the absence of K+ was 344 nm 
whereas it was 356 nm for the BADH with 
K+. This indicates a tryptophan spatial 
change in the protein owing to the presence 
of K+. The change in enzyme maximum and 
red shift of fluorescence emission depends 
on incubation time (Fig. 5B). For the 
enzyme incubated for 30 min with 1 mM 
Mn2+ in absence of K+, the fluorescence 
spectral center of mass was 7 nm different 
from the enzyme at the start of incubation. 
Similar results were found for the enzyme 
in the presence of K+. 
 
As demonstrated for other proteins and 
other divalent cations (Johnson et al., 1986; 
Zhang et al., 2001; Broder and Miller, 
2003), Mn2+ increased the exposure of the 
BADH tryptophan residues to the aqueous 
solvent, which suggests that Mn2+ 
inactivation of kidney BADH could be 
produced by changes in its tertiary structure. 
This change in protein tertiary structure 
decreases the BADH activity.  
 
In conclusion, the results of this study 
indicate that mammal renal BADH is a 
target of manganese toxicity, and at least 
one adverse effect could be a decrease in 
glycine betaine synthesis. This osmolyte 
plays a key role in osmoregulation and in 
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counteracting the adverse effects of urea in 
renal medulla cells (Burg, 1995; Bagnasco 
et. al., 1986). A decrease in glycine betaine 
synthesis and therefore in its concentration, 
would negatively affect the normal renal 
osmoregulation mechanism and induce a 
deficient protection of proteins from the 
deleterious effect of the urea. The renal 
damage demonstrated to rat kidneys could 
be related with a deficient enzymes 
activities, like showed in this work 
(Atessahin et al., 2003; Ponnapakkam et al., 
2003). 
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Figure 5: Kidney BADH fluorescence spectra. (A) Effect of Mn2+ on 
fluorescence emission of: a) BADH in buffer A; b) BADH in buffer A plus 0.15 
M KCl; c) BADH in buffer A plus 1 mM MnCl2; d) BADH in buffer A plus 0.15 
M KCl and 1 mM MnCl2. (B) Effect of incubation time on the fluorescence 
spectra of the enzyme with MnCl2. e) BADH in buffer A plus 1 mM MnCl2; f) 
BADH incubated for 30 min at room temperature. 
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